Glaukos Corp Files 8-K on Aug 12, 2025
Ticker: GKOS · Form: 8-K · Filed: Aug 12, 2025 · CIK: 1192448
Sentiment: neutral
Topics: sec-filing, 8-k, regulation-fd
Related Tickers: GKOS
TL;DR
Glaukos filed an 8-K on 8/12/25, check for material updates.
AI Summary
Glaukos Corporation filed an 8-K on August 12, 2025, reporting under Regulation FD and including financial statements and exhibits. The filing details the company's principal executive offices located at One Glaukos Way, Aliso Viejo, California, 92656, and its telephone number (949) 367-9600. No specific financial results or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Glaukos Corporation is providing updates or disclosures required by the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing header and does not contain information about specific risks or material events.
Key Players & Entities
- Glaukos Corporation (company) — Registrant
- August 12, 2025 (date) — Date of earliest event reported
- One Glaukos Way, Aliso Viejo, California, 92656 (location) — Address of principal executive offices
- (949) 367-9600 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for Glaukos Corporation and is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits as of August 12, 2025.
When was this 8-K filing submitted?
The filing was submitted on August 12, 2025.
What is Glaukos Corporation's principal executive office address?
Glaukos Corporation's principal executive office is located at One Glaukos Way, Aliso Viejo, California, 92656.
What is Glaukos Corporation's telephone number?
Glaukos Corporation's telephone number is (949) 367-9600.
What is Glaukos Corporation's state of incorporation?
Glaukos Corporation is incorporated in Delaware.
Filing Stats: 504 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-08-12 07:00:14
Filing Documents
- gkos-20250812x8k.htm (8-K) — 37KB
- gkos-20250812xex99d1.htm (EX-99.1) — 48KB
- gkos-20250812xex99d1g001.jpg (GRAPHIC) — 71KB
- gkos-20250812xex99d1g002.jpg (GRAPHIC) — 337KB
- gkos-20250812xex99d1g003.jpg (GRAPHIC) — 131KB
- gkos-20250812xex99d1g004.jpg (GRAPHIC) — 118KB
- gkos-20250812xex99d1g005.jpg (GRAPHIC) — 85KB
- gkos-20250812xex99d1g006.jpg (GRAPHIC) — 148KB
- gkos-20250812xex99d1g007.jpg (GRAPHIC) — 146KB
- gkos-20250812xex99d1g008.jpg (GRAPHIC) — 118KB
- gkos-20250812xex99d1g009.jpg (GRAPHIC) — 109KB
- gkos-20250812xex99d1g010.jpg (GRAPHIC) — 172KB
- gkos-20250812xex99d1g011.jpg (GRAPHIC) — 121KB
- gkos-20250812xex99d1g012.jpg (GRAPHIC) — 113KB
- gkos-20250812xex99d1g013.jpg (GRAPHIC) — 119KB
- gkos-20250812xex99d1g014.jpg (GRAPHIC) — 131KB
- gkos-20250812xex99d1g015.jpg (GRAPHIC) — 117KB
- gkos-20250812xex99d1g016.jpg (GRAPHIC) — 153KB
- gkos-20250812xex99d1g017.jpg (GRAPHIC) — 154KB
- gkos-20250812xex99d1g018.jpg (GRAPHIC) — 161KB
- gkos-20250812xex99d1g019.jpg (GRAPHIC) — 126KB
- gkos-20250812xex99d1g020.jpg (GRAPHIC) — 84KB
- gkos-20250812xex99d1g021.jpg (GRAPHIC) — 136KB
- gkos-20250812xex99d1g022.jpg (GRAPHIC) — 163KB
- gkos-20250812xex99d1g023.jpg (GRAPHIC) — 115KB
- gkos-20250812xex99d1g024.jpg (GRAPHIC) — 169KB
- gkos-20250812xex99d1g025.jpg (GRAPHIC) — 146KB
- gkos-20250812xex99d1g026.jpg (GRAPHIC) — 132KB
- gkos-20250812xex99d1g027.jpg (GRAPHIC) — 48KB
- gkos-20250812xex99d1g028.jpg (GRAPHIC) — 61KB
- gkos-20250812xex99d1g029.jpg (GRAPHIC) — 56KB
- 0001558370-25-011142.txt ( ) — 5310KB
- gkos-20250812.xsd (EX-101.SCH) — 3KB
- gkos-20250812_lab.xml (EX-101.LAB) — 15KB
- gkos-20250812_pre.xml (EX-101.PRE) — 10KB
- gkos-20250812x8k_htm.xml (XML) — 5KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. Glaukos Corporation (the "Company") intends to present the materials attached as Exhibit 99.1 to this Current Report on Form 8-K (the "Investor Presentation") from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company's website at http://investors.glaukos.com. The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Investor Presentation, dated August 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLAUKOS CORPORATION (Registrant) By: /s/ Alex R. Thurman Name: Alex R. Thurman Title: Senior Vice President & Chief Financial Officer Date: August 12, 2025